Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, QUARZAN to SYPRINE Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS QUARZAN to SYPRINE Trade Name Generic QUARZAN *Clidinium QUESTRAN Cholestyramine QUINAGLUTE Quinidine RAXAR Grepafloxacin REBETRON Ribavirin RECOMBIVAX HB Hepatitis B vaccine REGITINE Phentolamine REGLAN Metoclopramide RELAFEN Nabumetone RELENZA Zanamivir REOPRO Abciximab REQUIP Ropinirole...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, Paclitaxel to Rosiglitazone Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Paclitaxel to Rosiglitazone Generic Trade Name Paclitaxel TAXOL Pamidronate AREDIA Pancrelipase PANCREASE, VIOKASE Pancuronium PAVULON Papaverine PAVABID Paramethadione PARADIONE Paramethasone HALDRONE Pargyline EUTONYL Paromomycin HUMATIN Paroxetine PAXIL Penbutolol LEVATOL Penciclovir DENAVIR...
SY161, a cost-effective treatment of acute myocardial infarction - - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
Centocor Company Timeline Our Business Partners Investor Information - Our Achievements in Science & Research Our Achievements in Business Mid-1970s Researchers at the laboratory for Molecular Biology in Cambridge, U.K., successfully fuse a myeloma cancer cell with an immune cell to create a new hybrid, a hybridomaRETAVASE ...
Centocor Media Resources Disease Information Go to www.retavase.com - RETAVASE ® (Reteplase recombinant) is a potent fibrinolytic which is commonly referred to as a "clot buster." It is administered for the treatment of acute myocardial infarction (heart attack)RETAVASE is designed with high fibrin specificity and moderate fibrin affinity to penetrate the clot...
Centocor RETAVASE ® (Reteplase recombinant) Breaking barriers to heart attack treatment
Centocor ReoPro ® (abciximab) A market leader in coronary careRETAVASE ® (Reteplase recombinant) Breaking barriers to heart attack treatment
Centocor - Media Resources Centocor Completes Acquisition of Wyeth StRETAVASE ® (Reteplase recombinant)
Therapeutic Biological Approvals FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -Therapeutic Biological Approvals - Tradename/ Proper Name Indication for Use STN Manufacturer/ License No
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, QUARZAN to SYPRINE Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS QUARZAN to SYPRINE Trade Name Generic QUARZAN *Clidinium QUESTRAN Cholestyramine QUINAGLUTE Quinidine RAXAR Grepafloxacin REBETRON Ribavirin RECOMBIVAX HB Hepatitis B vaccine REGITINE Phentolamine REGLAN Metoclopramide RELAFEN Nabumetone RELENZA Zanamivir REOPRO Abciximab REQUIP Ropinirole...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, Paclitaxel to Rosiglitazone Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Paclitaxel to Rosiglitazone Generic Trade Name Paclitaxel TAXOL Pamidronate AREDIA Pancrelipase PANCREASE, VIOKASE Pancuronium PAVULON Papaverine PAVABID Paramethadione PARADIONE Paramethasone HALDRONE Pargyline EUTONYL Paromomycin HUMATIN Paroxetine PAXIL Penbutolol LEVATOL Penciclovir DENAVIR...
Reteplase - Product Approval Information - Licensing Action FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -Reteplase Product Approval Information - Licensing Action Proper name: Reteplase Tradename: Retavase Manufacturer: Boehringer Mannheim GmbH, Werk Penzberg, Federal Republic of Germany, License #1211 Indication for Use: In the management of acute myocardial infarction (AMI)...
Violative Advertising & Promotional Labeling Letters - Therapeutic Biological Products FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -Violative Advertising & Promotional Labeling Letters Therapeutic Biological Products Botulinum Toxin Type A, BOTOX Cosmetic - 6/23/2003 - Allergan, Inc - (PDF) , (Text) Botulinum Toxin Type A, BOTOX Cosmetic - 9/5/2002 - Allergan, Inc - (PDF) , (Text) Epoetin alfa, Procrit - 6/20/2003 -...
Prescription Drug User Fee Act - User Fee Billable Therapeutic Products: Approved Under Section 351 of the PHS Act FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER Prescription Drug User Fee Act User Fee Billable Therapeutic Products Approved Under Section 351 of the PHS Act This list is intended to include all the user fee billable therapeutic biological products and potencies approved under Section 351 of the Public Health Service Act that have been transferred...
Centocor ReoPro ® (abciximab) A market leader in coronary careRETAVASE ® (Reteplase recombinant) Breaking barriers to heart attack treatment
Issued: 01-25-1999 Important Drug Warning Safety Info Urokinase (Abbokinase) market with well- described experience in multiple indications include Streptase@ (Streptokinase), Kabikinase@ (Streptokinase), Activase@ (Alteplase), Eminase@ (Anistreplase), and Retavase@ (Reteplase)
author: CBER FDA
subject: Safety Info Urokinase (Abbokinase)
Issued: 01-25-1999 Important Drug Warning Safety Info Urokinase (Abbokinase) page 2
author: CBER FDA
subject: Safety Info Urokinase (Abbokinase)
CBER Transfer of Therapeutic Products to CDER Alteplase Activase Genentech, Inc Anakinra Kineret Amgen, Inc Anistreplase Eminase Wulfing Pharma GmbH Arcitumomab CEA-Scan Immunomedics, Inc Asparaginase Elspar Merck & Co., Inc Basiliximab Simulect Novartis Pharmaceuticals Corp Becaplermin Regranex OMJ Pharmaceuticals, Inc Becaplermin Concentrate - Chiron Corp Botulinum Toxin Type A BOTOX BOTOX COSMETIC Allergan, Inc Botulinum...
author: FDA / CBER
Acute Myocardial Infarction Benefits and Risks of Thrombolytics Alteplase (t-PA, rt-PA, Activase) Benefits: - 10 yrs clinical experience -1 million patients treated Fibrin specificity Weight-dosed regimen 30 day mortality: 6.3% (GUSTO I) ICH rate:- 0.7% (GUSTO I) Reteplase (rPA, Retavase) Benefits: Double bolus dosing 30 day mortality: 7.47% (GUSTO III) ICH rate:--- 0.91% (GUSTO III) Streptokinase ...
DRUG DOSING GUIDELINES Enoxaparin (Lovenox): Dose for NSTE/ACS: 1 mg/kg sc q12 hr Dose for STE/ACS: 30 mg IV bolus followed immediately by 1 mg/kg sc q12 hr Dose for PCI in patients with NSTE/ACS: If last dose administered < 8 hrs, no supplemental enoxaparin (or unfractionated heparin) dose needed; if last dose administered more than 8 hours (and less than 12 hrs), administer 0.3 mg/kg IV bolus Avoid in...
http://www.ahcpub.com/ahc_root_html/hot/ThrombosisPosters/DrugDosingACS.pdf Enoxaparin (Lovenox): Dose for NSTE/ ACS: 1 mg/ kg sc q12 hr Dose for STE/ ACS: 30 mg IV bolus followed immediately by 1 mg/ kg sc q12 hr Dose for PCI in patients with NSTE/ ACS: If last dose administered < 8 hrs, no supplemental enoxaparin (or unfractionated heparin) dose needed; if last dose administered more than 8 hours (and less than 12 hrs), administer 0.3 mg/ kg IV bolus Avoid...
Heart Attack: Coronary Artery Disease: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
EntreMed Sells Thalidomide Royalty Stream for $24.3 Million :: EntreMed, Inc. EntreMed Site Search: Contact Us | Site Map Corporate Summary Pipeline Therapeutic Pathways Investor Relations Media Center Electronic Media Kit Press Releases Press Release Archives Press Release Search Clinical Trials --•-- News --•-- Recent Presentations --•-- SEC Filings Press Release Archives EntreMed Sells Thalidomide Royalty Stream for $24.3 Million Additional...
